Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 3719

1.

Treating patients with venous thromboembolism: initial strategies and long-term secondary prevention.

Huisman MV, Bounameaux H.

Semin Vasc Med. 2005 Aug;5(3):276-84.

PMID:
16123915
[PubMed - indexed for MEDLINE]
2.

The role of ximelagatran in the treatment of venous thromboembolism.

Schulman S.

Pathophysiol Haemost Thromb. 2005;34 Suppl 1:18-24. Review.

PMID:
15812200
[PubMed - indexed for MEDLINE]
3.

Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.

Colwell C, Mouret P.

Semin Vasc Med. 2005 Aug;5(3):266-75. Review.

PMID:
16123914
[PubMed - indexed for MEDLINE]
4.

Prevention of stroke in patients with atrial fibrillation.

Olsson SB, Halperin JL.

Semin Vasc Med. 2005 Aug;5(3):285-92. Review.

PMID:
16123916
[PubMed - indexed for MEDLINE]
5.

Emerging options in the treatment of venous thromboembolism.

Nutescu EA.

Am J Health Syst Pharm. 2004 Dec 1;61(23 Suppl 7):S12-7. Review.

PMID:
15597574
[PubMed - indexed for MEDLINE]
6.

Ximelagatran.

Choudhury A, Goyal D, Lip GY.

Drugs Today (Barc). 2006 Jan;42(1):3-19. Review.

PMID:
16511607
[PubMed - indexed for MEDLINE]
7.

Treatment of venous thromboembolism and long-term prevention of recurrence: present treatment options and ximelagatran.

Eriksson H.

Drugs. 2004;64 Suppl 1:37-46. Review.

PMID:
15586626
[PubMed - indexed for MEDLINE]
8.

Treatment of venous thromboembolism with the oral thrombin inhibitor, ximelagatran.

Harenberg J, Ingrid J, Tivadar F.

Isr Med Assoc J. 2002 Nov;4(11):1003-5.

PMID:
12489490
[PubMed - indexed for MEDLINE]
Free Article
9.

Prognostic factors for recurrence of venous thromboembolism (VTE) or bleeding during long-term secondary prevention of VTE with ximelagatran.

Eriksson H, Lundström T, Wåhlander K, Clason SB, Schulman S; THRIVE III Investigators.

Thromb Haemost. 2005 Sep;94(3):522-7.

PMID:
16268466
[PubMed - indexed for MEDLINE]
10.

Ximelagatran: a new oral anticoagulant.

Hrebickova L, Nawarskas JJ, Anderson JR.

Heart Dis. 2003 Nov-Dec;5(6):397-408. Review.

PMID:
14633322
[PubMed - indexed for MEDLINE]
11.

Treatment of DVT: how long is enough and how do you predict recurrence.

Agnelli G, Becattini C.

J Thromb Thrombolysis. 2008 Feb;25(1):37-44. Epub 2007 Oct 1. Review.

PMID:
17906973
[PubMed - indexed for MEDLINE]
12.

Clinical experience with ximelagatran in orthopaedic surgery.

Eriksson B.

Drugs. 2004;64 Suppl 1:27-35. Review.

PMID:
15586625
[PubMed - indexed for MEDLINE]
13.

Ximelagatran: an orally active direct thrombin inhibitor.

Gulseth MP.

Am J Health Syst Pharm. 2005 Jul 15;62(14):1451-67. Review.

PMID:
15998925
[PubMed - indexed for MEDLINE]
14.

New blood thinner offers first potential alternative in 50 years: ximelagatran.

Nutescu EA, Helgason CM, Briller J, Schwertz DW.

J Cardiovasc Nurs. 2004 Nov-Dec;19(6):374-83. Review.

PMID:
15529058
[PubMed - indexed for MEDLINE]
15.

Ximelagatran versus warfarin for the prevention of venous thromboembolism after total knee arthroplasty. A randomized, double-blind trial.

Francis CW, Davidson BL, Berkowitz SD, Lotke PA, Ginsberg JS, Lieberman JR, Webster AK, Whipple JP, Peters GR, Colwell CW Jr.

Ann Intern Med. 2002 Oct 15;137(8):648-55.

PMID:
12379064
[PubMed - indexed for MEDLINE]
16.

Ximelagatran for treatment and prophylaxis of recurrent events in deep vein thrombosis.

Koscielny J, Kiesewetter H, Jörg I, Harenberg J.

Clin Appl Thromb Hemost. 2007 Jul;13(3):299-307. Review.

PMID:
17636192
[PubMed - indexed for MEDLINE]
17.

Incidence of recurrent venous thromboembolism of patients after termination of treatment with ximelagatran.

Harenberg J, Jörg I, Weiss C.

Eur J Clin Pharmacol. 2006 Mar;62(3):173-7. Epub 2006 Jan 14.

PMID:
16416154
[PubMed - indexed for MEDLINE]
18.

New anticoagulants for treatment of venous thromboembolism.

Weitz JI.

Circulation. 2004 Aug 31;110(9 Suppl 1):I19-26. Review.

PMID:
15339877
[PubMed - indexed for MEDLINE]
Free Article
19.

Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement. A randomized, double-blind study.

Colwell CW Jr, Berkowitz SD, Davidson BL, Lotke PA, Ginsberg JS, Lieberman JR, Neubauer J, McElhattan JL, Peters GR, Francis CW.

J Thromb Haemost. 2003 Oct;1(10):2119-30.

PMID:
14521593
[PubMed - indexed for MEDLINE]
20.

Prevention of venous thromboembolism following orthopaedic surgery: clinical potential of direct thrombin inhibitors.

Eriksson BI, Dahl OE.

Drugs. 2004;64(6):577-95. Review. Erratum in: Drugs. 2004;64(8):912.

PMID:
15018589
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk